Dexmedetomidine Versus Midazolam for Facilitating Extubation
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this randomized, double-blind study is to evaluate the utility, safety, and
cost of transitioning benzodiazepine sedation to dexmedetomidine in medical or surgical
intensive care unit (ICU) patients requiring sedation when tracheal extubation is nearing.
Fifty medical or surgical ICU patients requiring sedation with existing benzodiazepine
therapy and qualifying for daily awakenings will be randomized in a double-blind manner to
receive additional midazolam or dexmedetomidine.
Phase:
N/A
Details
Lead Sponsor:
University of Colorado, Denver
Collaborators:
Hospira, Inc. Hospira, now a wholly owned subsidiary of Pfizer